CytoSorbents to Report Q1 2021 Operating and Financial Results News provided by Share this article Share this article MONMOUTH JUNCTION, N.J., April 27, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q1 2021 financial results after the market close on Tuesday, May 4, 2021 at 4:45PM EST. CytoSorbents' management will host a live conference call and presentation webcast that will recount both operational and financial progress during Q1 2021 followed by a question and answer session. CytoSorbents Corporation to Report Q1 2021 Operating and Financial Results on Tuesday, May 4, 2021